In Memory of Hugo W. Moser, MD (1924–2007) James A. Hamilton Acknowledgments 09 August 2007 Pages: 1 - 1
Brain Uptake and Utilization of Fatty Acids, Lipids and Lipoproteins: Application to Neurological Disorders James A. HamiltonCecilia J. HillardPaul A. Watkins EditorialNotes 26 July 2007 Pages: 2 - 11
A Model for Fatty Acid Transport into the Brain James A. HamiltonKellen Brunaldi OriginalPaper 04 July 2007 Pages: 12 - 17
Studies of Anandamide Accumulation Inhibitors in Cerebellar Granule Neurons: Comparison to Inhibition of Fatty Acid Amide Hydrolase Cecilia J. HillardLeyu ShiWilliam B. Campbell OriginalPaper 19 July 2007 Pages: 18 - 24
The Fatty Acid Transport Protein (FATP) Family: Very Long Chain Acyl-CoA Synthetases or Solute Carriers? Zhenzhen JiaZhengtong PeiPaul A. Watkins OriginalPaper 30 June 2007 Pages: 25 - 31
The Role of Size and Charge for Blood–Brain Barrier Permeation of Drugs and Fatty Acids Anna Seelig OriginalPaper 27 June 2007 Pages: 32 - 41
Mechanisms of Intracellular Fatty Acid Transport: Role of Cytoplasmic-Binding Proteins Richard A. Weisiger OriginalPaper 26 June 2007 Pages: 42 - 44
Roundtable Discussion of Session 1: Mechanisms of Lipid Uptake and Transport in the Brain Paul A. WatkinsJames A. Hamilton Interview 27 June 2007 Pages: 45 - 50
Plasma 24S Hydroxycholesterol Response to Statins in Alzheimer’s Disease Patients: Effects of Gender, CYP46, and ApoE Polymorphisms Gloria Lena VegaMyron F. Weiner OriginalPaper 22 June 2007 Pages: 51 - 55
Role of Liver and Plasma Lipoproteins in Selective Transport of n-3 Fatty Acids to Tissues: A Comparative Study of 14C-DHA and 3H-Oleic Acid Tracers Alla PolozovaNorman Salem Jr OriginalPaper 01 August 2007 Pages: 56 - 66
Neuronal Specific Increase of Phosphatidylserine by Docosahexaenoic Acid Mingquan GuoLyubov StockertHee-Yong Kim OriginalPaper 07 July 2007 Pages: 67 - 73
Roundtable Discussion of Session 2: Lipoproteins and Polyunsaturated Fatty Acids Paul A. WatkinsJames A. Hamilton Interview 27 June 2007 Pages: 74 - 79
Electrophilic Cyclopentenone Isoprostanes in Neurodegeneration Erik S. MusiekBethAnn McLaughlinJason D. Morrow OriginalPaper 30 June 2007 Pages: 80 - 86
Endocannabinoid Liberation from Neurons in Transsynaptic Signaling David M. Lovinger OriginalPaper 21 June 2007 Pages: 87 - 93
Function of COX-2 and Prostaglandins in Neurological Disease X. LiangL. WuK. Andreasson OriginalPaper 17 July 2007 Pages: 94 - 99
Roundtable Discussion of Session 3: Eicosanoids in Brain Function Paul A. WatkinsJames A. Hamilton Interview 28 June 2007 Pages: 100 - 104
“Lorenzo’s Oil” Therapy for X-linked Adrenoleukodystrophy: Rationale and Current Assessment of Efficacy Hugo W. MoserAnn B. MoserGerald V. Raymond OriginalPaper 24 August 2007 Pages: 105 - 113
F2-Isoprostanes as Biomarkers of Late-onset Alzheimer’s Disease Thomas J. MontineJoseph QuinnJason D. Morrow OriginalPaper 22 June 2007 Pages: 114 - 119
Roundtable Discussion of Session 4: Fatty Acids and Lipids in Brain Disorders Paul A. WatkinsJames A. Hamilton Interview 27 July 2007 Pages: 120 - 124
Synopses of Posters Presented at the International Workshop on Brain Uptake and Utilization of Fatty Acids, Lipids, and Lipoproteins: Application to Neurological Disorders Robert KatzPaul A. Watkins EditorialNotes 26 June 2007 Pages: 125 - 128
Brain Uptake and Utilization of Fatty Acids, Lipids & Lipoproteins: Recommendations for Future Research Robert KatzJames A. HamiltonPaul A. Watkins EditorialNotes 26 July 2007 Pages: 146 - 150
